Literature DB >> 20626583

Increased myocardial methionine-enkephalin with reduced arterial oxygenation in congenital heart disease.

Olivier W V van den Brink1, Andrew D Cochrane, Franklin L Rosenfeldt, Daniel J Penny, Salvatore Pepe.   

Abstract

BACKGROUND: Cardiac opioid peptides have been identified to exert important adaptive metabolic signalling for cardioprotection against ischaemia or hypoxia-related injury. AIMS: To determine myocardial methionine-enkephalin content in children with hypoxemic congenital heart defects and to correlate myocardial content of methionine-enkephalin with the extent of arterial oxygen desaturation.
METHODS: Children (n= 20, median age of 16 months), undergoing cardiac surgical repair (tetralogy of Fallot, 17/20), were included in this study. Arterial oxygen saturation was measured on admission. Myocardial samples obtained during surgery were assayed via radioimmunochemistry for methionine-enkephalin content.
RESULTS: Greater methionine-enkephalin content was measured in the right ventricles of the patients suffering from recent cyanotic spells compared with those with no recent spells (cyanotic spells: 2418 ± 844 pg/g wet weight tissue, n= 6; no spells: 1175 ± 189 pg/g wet weight tissue, n= 14, P= 0.04). An inverse correlation was evident between the arterial oxygen saturation and myocardial methionine-enkephalin content.
CONCLUSION: Myocardial methionine-enkephalin levels increase with the severity of hypoxic stress in congenital cardiac disease and may play an important adaptive role in countering adrenergic over-activity and related excess demand on myocardial metabolic capacity.
© 2010 The Authors. Journal compilation © 2010 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Keywords:  congenital heart defects; enkephalin; hypoxia; opioid peptide; tetralogy of Fallot

Mesh:

Substances:

Year:  2010        PMID: 20626583     DOI: 10.1111/j.1440-1754.2010.01794.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  2 in total

1.  Remote ischemic preconditioning attenuates cardiopulmonary bypass-induced lung injury.

Authors:  Xiaona Zhou; Runzhu Jiang; Yucai Dong; Lifeng Wang
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

2.  Effect of remote ischemic preconditioning on phosphorylated protein signaling in children undergoing tetralogy of Fallot repair: a randomized controlled trial.

Authors:  Salvatore Pepe; Norman Y Liaw; Michele Hepponstall; Freya L Sheeran; Matthew S Yong; Yves d'Udekem; Michael M Cheung; Igor E Konstantinov
Journal:  J Am Heart Assoc       Date:  2013-05-10       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.